Company Description
Movano Inc., a technology company, engages in the development of a platform to deliver healthcare solutions at the intersection of medical and consumer devices.
It offers Evie Ring, a wearable device for women that combines health and wellness metrics comprising resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
The company develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems.
It sells its products through its website, retail or other distribution channels, value-added resellers (VARs), as well as partnering with OEMs.
The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018.
Movano Inc. was incorporated in 2018 and is headquartered in Pleasanton, California.
| Country | United States |
| Founded | 2018 |
| IPO Date | Mar 23, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 32 |
| CEO | John Mastrototaro |
Contact Details
Address: 6800 Koll Center Parkway Pleasanton, California 94566 United States | |
| Phone | 415 651 3172 |
| Website | movano.com |
Stock Details
| Ticker Symbol | MOVE |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $5.00 |
| CIK Code | 0001734750 |
| CUSIP Number | 62459M107 |
| ISIN Number | US62459M2061 |
| Employer ID | 82-4233771 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. John Mastrototaro Ph.D. | Chief Executive Officer, President and Director |
| Michael Aaron Leabman | Founder, Chief Technology Officer and Director |
| Jeremy Cogan C.F.A. | Chief Financial Officer and Secretary |
| Tyla Bucher | Chief Marketing Officer |
| Phil Kelly | Senior Vice President of Engineering |
| Michael Soule | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 29, 2025 | ARS | Filing |
| Aug 29, 2025 | DEF 14A | Other definitive proxy statements |
| Aug 28, 2025 | 8-K | Current Report |
| Aug 22, 2025 | 8-K | Current Report |
| Aug 19, 2025 | PRE 14A | Other preliminary proxy statements |
| Aug 15, 2025 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
| Aug 15, 2025 | 8-K | Current Report |
| Aug 7, 2025 | 8-K | Current Report |
| Jul 11, 2025 | 8-K | Current Report |
| Jun 25, 2025 | 8-K | Current Report |